 |
bupivacaine |
|---|---|
| Trade Name | Transdur |
| Orphan Indication | Relief of persistent pain associated with postherpetic neuralgia |
| USA Market Approval | USA |
| USA Designation Date | 2008-06-18 00:00:00 |
| Sponsor | DURECT Corporation;10260 Bubb Road;Cupertino, California, 95014 |
